Pfizer Inc (PFE.N) reported a higher-than-expected third-quarter profit on Tuesday on increased sales of cancer drug Ibrance and a strong launch of new heart medicine Vyndaqel,...
German biotech company Morphosys halted development of an experimental atopic dermatitis treatment that analysts had pinned hopes of blockbuster sales potential on, sending its shares down...
An experimental drug from Mirati Therapeutics that targets a specific genetic mutation significantly reduced tumor size in 40% of patients with advanced lung and colorectal cancer so far...
Tablets are used for treatment of erosive esophagitis associated with gastroesophageal reflux disease Jubilant Cadista Pharmaceuticals Inc is recalling 63,216 bottles of Pantoprazole Sodium delayed-release tablets...
Non-profit drug developer TB Alliance has granted Macleods Pharmaceuticals Limited a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug “BPaL” regimen....
Google owner Alphabet Inc has made an offer to acquire U.S. wearable device maker Fitbit Inc , as it eyes a slice of the crowded market...
Making a foray into the personal digital healthcare domain, Facebook has unveiled a ‘Preventive Health’ tool that connects people to health resources and sends check-up reminders....
China’s support for the modernization and strengthening of Ghana’s health sector and health service delivery continues to grow over the years. One of the areas which...
The Dubai Health Authority (DHA) has closed down a private hospital for three months for not complying with medical standards and regulations, it announced on Saturday....
Drugmaker Amgen Inc said on Thursday that starting next year, its official list price for cholesterol drug Repatha will be the lower price it began offering...
Vertex Pharmaceuticals Incorporated, a global biotechnology company, announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis (CF) medicines and any future...
Biopharmaceutical company, MediciNova, Inc has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-001 (tipelukast) for the treatment of...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the European Commission (EC) has approved the oral once-daily therapy XOSPATA™...
Japan has huge export potential in pharmaceuticals sector, exporters body Federation of Indian Export Organisations (FIEO) said, while addressing the session on Trade and Business Opportunities...
Castlight Health, Inc. (NYSE:CSLT), a leading health benefits platform provider, today announced results for its third quarter ended September 30, 2019. Recent Highlights Signed Anthem, Inc. to...
Copyright © 2024 Medical Buyer